SUMMIT SECURITIES GROUP LLC
Broker-DealerPosition in RVMD — Revolution Medicines, Inc.
CIK 1531593
NEW YORK, NY
Position in RVMD
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$38,900
-$101,711 QoQ
Shares Held
400
-89.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Dec 31, 2023CallValue
$43,020
CallShares
1,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUMMIT SECURITIES GROUP LLC holds $1,851,878 across 25 Biotechnology names. RVMD ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
23,000 | $1,212,560 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
138 | $106,624 | |
| 3 | MRNA |
Moderna, Inc.
|
1,626 | $82,600 | |
| 4 | CRMD |
CorMedix Inc.
|
10,256 | $69,638 | |
| 5 | FULC |
Fulcrum Therapeutics, Inc.
|
6,975 | $53,498 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
1,197 | $46,072 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
460 | $42,494 | |
| 8 | RVMD |
Revolution Medicines, Inc.
This page
|
400 | $38,900 |
All Filings in RVMD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,900 | 400 | Shares | Sole | 2026-04-30 | |
| 2025-06-30 | $140,611 | 3,822 | Shares | Sole | 2025-08-12 | |
| 2023-12-31 | $702,660 | 24,500 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $43,020 | 1,500 | Call | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||